User profiles for Sarah Adamo
Sarah AdamoCenter for Infectious Medicine, Karolinska Insitutet, Stockholm Verified email at ki.se Cited by 1115 |
[HTML][HTML] Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
Background Whereas severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific
antibody tests are increasingly being used to estimate the prevalence of SARS-CoV-2 …
antibody tests are increasingly being used to estimate the prevalence of SARS-CoV-2 …
[HTML][HTML] Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome
Following acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
a significant proportion of individuals develop prolonged symptoms, a serious condition …
a significant proportion of individuals develop prolonged symptoms, a serious condition …
[HTML][HTML] Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection
Immunological memory is a hallmark of adaptive immunity and facilitates an accelerated
and enhanced immune response upon re-infection with the same pathogen 1 , 2 . Since the …
and enhanced immune response upon re-infection with the same pathogen 1 , 2 . Since the …
Multisystemic and multiresistant Langerhans cell histiocytosis: a case treated with BRAF inhibitor
L Gandolfi, S Adamo, A Pileri, A Broccoli… - Journal of the National …, 2015 - jnccn.org
Langerhans cell histiocytosis (LCH) is a rare proliferative disease with a wide spectrum of
clinical presentations and, as a consequence, the treatment choice is unclear. Recently, …
clinical presentations and, as a consequence, the treatment choice is unclear. Recently, …
[HTML][HTML] A machine learning approach to predict the rehabilitation outcome in convalescent COVID-19 patients
S Adamo, P Ambrosino, C Ricciardi, M Accardo… - Journal of Personalized …, 2022 - mdpi.com
Background: After the acute disease, convalescent coronavirus disease 2019 (COVID-19)
patients may experience several persistent manifestations that require multidisciplinary …
patients may experience several persistent manifestations that require multidisciplinary …
[PDF][PDF] A distinct innate immune signature marks progression from mild to severe COVID-19
Coronavirus disease 2019 (COVID-19) manifests with a range of severities, but immune
signatures of mild and severe disease are still not fully understood. Here, we use mass …
signatures of mild and severe disease are still not fully understood. Here, we use mass …
[HTML][HTML] Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2
Y Zurbuchen, J Michler, P Taeschler, S Adamo… - Nature …, 2023 - nature.com
The B cell response to different pathogens uses tailored effector mechanisms and results in
functionally specialized memory B (B m ) cell subsets, including CD21 + resting, CD21 – …
functionally specialized memory B (B m ) cell subsets, including CD21 + resting, CD21 – …
SARS-CoV-2 vaccination enhances the effector qualities of spike-specific T cells induced by COVID-19
T cells are critical for immune protection against severe COVID-19, but it has remained
unclear whether repeated exposure to SARS-CoV-2 antigens delivered in the context of …
unclear whether repeated exposure to SARS-CoV-2 antigens delivered in the context of …
Persistent complement dysregulation with signs of thromboinflammation in active Long Covid
Long Covid is a debilitating condition of unknown etiology. We performed multimodal
proteomics analyses of blood serum from COVID-19 patients followed up to 12 months after …
proteomics analyses of blood serum from COVID-19 patients followed up to 12 months after …
Profound dysregulation of T cell homeostasis and function in patients with severe COVID‐19
Background Coronavirus disease 2019 (COVID‐19) is caused by infection with severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and shows a broad clinical …
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and shows a broad clinical …